Hoylu - ARR Growth with Lower Costs
2022-07-25 07:19:00
Redeye raises its Base Case following Hoylu’s Q2’22 report. Overall, the report was somewhat above our expectations, with a higher-than-expected total ARR, and lower-than-expected costs, which saw solid sequential improvement versus Q1. As such, we make slight 2022E and 2023E forecast adjustments.
Read more and download the Research Update.
Follow companies at Redeye to receive the latest equity research within Life Science and Technology.
This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/